The price of Precigen Inc (NASDAQ: PGEN) closed at $1.39 in the last session, down -8.82% from day before closing price of $1.53. In other words, the price has decreased by -$0.1350 from its previous closing price. On the day, 1479133 shares were traded.
Ratios:
We take a closer look at PGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 346.00M and an Enterprise Value of 290.24M. For the stock, the TTM Price-to-Sale (P/S) ratio is 55.83 while its Price-to-Book (P/B) ratio in mrq is 2.93. Its current Enterprise Value per Revenue stands at 46.62 whereas that against EBITDA is -3.25.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 1.4486, while the 200-Day Moving Average is calculated to be 1.3264.
Shares Statistics:
According to the various share statistics, PGEN traded on average about 1.19M shares per day over the past 3-months and 1.22M shares per day over the past 10 days. A total of 248.92M shares are outstanding, with a floating share count of 123.71M. Insiders hold about 50.30% of the company’s shares, while institutions hold 30.46% stake in the company. Shares short for PGEN as of Feb 29, 2024 were 17.27M with a Short Ratio of 14.57, compared to 18.71M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.94% and a Short% of Float of 11.69%.
Earnings Estimates
The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.09, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.26 and -$0.37 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.26, with 5 analysts recommending between -$0.13 and -$0.42.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $38.45M in the next fiscal year. The high estimate is $104.93M and the low estimate is $7M. The average revenue growth estimate for next year is up 572.20% from the average revenue estimate for this year.
